Industrial Purity 5-Azacytidine Coa Specification Verification

• [Analytical Metrics] HPLC assay targets ≥98.0% purity with strict heavy metal controls ≤20 ppm.
• [Storage Protocols] Cryogenic storage at -20°C ensures batch-to-batch consistency and stability.
• [Compliance Standards] Full documentation supports cGMP compliance and regulatory audit readiness.

Securing reliable supply chains for critical pharmaceutical intermediates requires rigorous verification of quality documentation. For 5-Azacytidine (CAS: 320-67-2), the Certificate of Analysis (COA) serves as the primary document for validating industrial purity and safety profiles. As a potent demethylating agent used in oncology research and therapeutic development, maintaining exacting standards across synthesis and distribution is non-negotiable. NINGBO INNO PHARMCHEM CO.,LTD. operates as a premier global manufacturer, ensuring that every batch meets stringent pharmacopeial requirements before leaving the facility.

Procurement teams and quality assurance officers must scrutinize COA data to mitigate risks associated with impurity profiles and degradation. This technical overview details the critical parameters for verification, ensuring that sourced materials align with commercial-grade expectations for large-scale production.

Interpreting HPLC Assay Data ≥98.0% from COA

For process chemists and R&D departments, the High-Performance Liquid Chromatography (HPLC) assay is the definitive metric for chemical identity and potency. A robust synthesis route for 5-Azacytidine must minimize related substances and degradation products, particularly given the compound's sensitivity to hydrolysis. The standard specification typically demands a purity level of ≥98.0%, with top-tier batches often achieving 99.0% or higher.

When evaluating the chemical structure, specifically 4-Amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one, analysts should verify that the retention time matches the reference standard precisely. Impurities arising from incomplete glycosylation or deamination during the manufacturing process can significantly impact biological activity. Therefore, the COA must detail not only the main peak area but also specify limits for individual unknown impurities, typically capped at 0.10% to 0.15% per unknown. Consistent reaction yields and purified crystallization steps are essential to meeting these tight tolerances.

Heavy Metals and Residue on Ignition Limits

Executive oversight and regulatory compliance hinge on safety data regarding elemental impurities. Heavy metal contamination poses significant risks in pharmaceutical applications, necessitating strict adherence to limits such as ≤20 ppm. The COA should explicitly state the methods used for detection, often aligning with ICH Q3D guidelines or pharmacopeial standards like USP <231>.

Furthermore, Residue on Ignition (ROI) tests verify the inorganic content remaining after combustion, with a standard specification of ≤0.5%. High-quality batches typically demonstrate results as low as 0.12%, indicating effective purification during production. Loss on Drying (LOD) is another critical parameter, ensuring moisture content remains ≤1.0% to prevent hydrolytic degradation during storage. These metrics confirm that the material is safe for downstream formulation and meets the safety thresholds required for clinical or research use.

Requesting Custom COA and Certificates of Origin

For procurement specialists, verifying the supply chain origin is as vital as the chemical specifications themselves. Sourcing from a verified global manufacturer ensures access to batch-specific documentation, including Certificates of Origin and Stability Data. When sourcing high-purity 5-triazin-2(1H)-one intermediates, buyers should request a full audit trail to confirm regulatory compliance such as REACH or TSCA where applicable.

Commercial viability depends on transparent pricing and supply stability. Understanding the bulk price structure requires analyzing the cost implications of storage and logistics, as this compound requires cold chain management. A reliable partner will provide a comprehensive COA with every shipment, allowing quality control teams to perform incoming inspection verification without delay. This transparency reduces lead times and ensures continuity in production schedules.

Test Parameter	Specification Limit	Typical Result (Industrial Grade)
Appearance	White to off-white crystalline powder	Off-white crystalline powder
Purity (HPLC)	≥98.0%	99.0%
Loss on Drying	≤1.0%	0.78%
Residue on Ignition	≤0.5%	0.12%
Heavy Metals	≤20 ppm	<20 ppm

Maintaining the integrity of this nucleoside analogue requires strict adherence to storage recommendations, typically at -20°C, to preserve potency over the retest period. NINGBO INNO PHARMCHEM CO.,LTD. emphasizes batch-to-batch consistency, ensuring that every lot delivered matches the technical specifications outlined in the initial qualification phase.

To secure tonnage quantities or request sample evaluation, contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote.